Vaccine Capabilities

Vaccine Capabilities

Clinical Trial Site or Network

Information

Excellence in Delivery • Over 350 vaccine trials randomizing 21,500+ volunteers • Fully enrolled or exceeded goal for 99% of vaccine trials • Rapid start-up & multi-site SIVs and activation • Data entry and query resolution within 24 hours • Access to pediatric through geriatric populations • High-volume, rapid-timeline enrollment process Case Studies: • Enrolled 1505 volunteers in an influenza vaccine trial across 9 sites, 445 of whom were enrolled in one Sunday. • Enrolled 1251 volunteers across 5 sites for a Respiratory Syncytial Virus (RSV) vaccine trial, with a screen fail rate of 1.8%, in 4 weeks.
PMG ResearchPMG Research, Inc. is an integrated network of clinical research facilities with hub sites located in 14 cities in the Southeastern and Midwestern United States. PMG has conducted over 8,300 research studies for hundreds of pharmaceutical sponsors and CROs since 1979. It has extensive experience conducting all phases of trials across more than twenty therapeutic areas. PMG’s goal is to bring clinical research to as many lives as possible while delivering unparalleled service and exceptional value to clinical trial partners and stakeholders. To learn more, visit www.pmg-research.com. We are excited to announce that we will be changing our name to Accellacare in 2021, while expanding our research participation opportunities across the globe.   Accellacare includes previously acquired PMG Research in the US and MeDiNova Research in EMEA.  It extends across the globe  with 77 active research sites in seven countries with particular expertise in12 therapeutic areas. It has relationships with 275 Principal Investigators connecting it to 8 million+ patients. Patient care is at the heart of everything we do, and we are committed to  ensuring the same level of care PMG Research is known for. The name change will not affect our current locations in any way. Our new name represents our continued commitment to our patients and local communities while encompassing our new global reach, including locations in Europe, theMiddle East, and Africa. We thank you for your continued support and helping us shape the future of world health for you and future generations.

Log in